Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

ClinicalTrials.gov ID: NCT07153471

Public ClinicalTrials.gov record NCT07153471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 10:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.

Study identification

NCT ID
NCT07153471
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
800 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2025 (Actual)
Primary completion
Apr 2028 (Estimated)
Completion
May 2028 (Estimated)
Last update posted
Oct 8, 2026

2025 – 2028

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053 —
AMR Clinical Tempe Arizona 85281 —
Care Access - Huntington Beach Huntington Beach California 92648 —
Care Access - Thousand Oaks Thousand Oaks California 91360 —
Legacy Clinical Trials Colorado Springs Colorado 80909 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Care Access - Decatur Decatur Georgia 30030 —
North Georgia Clinical Research Woodstock Georgia 30189 —
Northwestern University Chicago Illinois 60611 —
AMR Clinical Newton Kansas 67114 —
MedVadis Research Corporation Waltham Massachusetts 02451 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
AMR Clinical Kansas City Missouri 64114 —
Cardio Metabolic Institute Somerset New Jersey 08873 —
Carolina Research Center Shelby North Carolina 28150 —
University Orthopedics Center Altoona Pennsylvania 16602 —
Care Access - Rapid City Rapid City South Dakota 57701 —
AMR Clinical Knoxville Tennessee 37909 —
Mercy Family Clinic Dallas Texas 75208 —
Juno Research Houston Texas 77040 —
Biopharma Informatic, LLC Houston Texas 77084 —
Activian Clinical Research Kingwood Texas 77339 —
Advanced Rheumatology of Houston - Woodlands The Woodlands Texas 77382 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Gershon Pain Specialists Virginia Beach Virginia 23454 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07153471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07153471 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →